BioNTech and Matinas end oral mRNA delivery collaboration
Matinas’ collaboration with Germany’s BioNTech has ended — after an attempt to deliver mRNA orally failed to work in mice.
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.